Panbela Therapeutics | PRER14A: Preliminary revised proxy soliciting materials
Apr 27 04:45
Panbela Therapeutics | DEFA14A: Others
Apr 26 04:42
Panbela Therapeutics | 8-K: Current report
Apr 26 04:41
Panbela Therapeutics | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Apr 25 21:15
Panbela Therapeutics | 8-K: Current report
Apr 22 20:05
Panbela Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Apr 19 04:33
Panbela Therapeutics | 8-K: Current report
Apr 17 20:39
Panbela Therapeutics | EFFECT: Others
Apr 17 18:10
Panbela Therapeutics | DEF 14A: Definitive information statements
Apr 5 04:22
Panbela Therapeutics | EFFECT: Others
Apr 3 18:07
Panbela Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933
Mar 30 05:28
Panbela Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 30 05:13
Panbela Therapeutics | 10-K: Annual report
Mar 27 04:20
Panbela Therapeutics | 8-K: Current report
Mar 27 04:16
Panbela Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Mar 26 04:22
Panbela Therapeutics | 8-K: Current report
Mar 7 19:05
Panbela Therapeutics | 8-K: Current report
Feb 15 21:07
Panbela Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0%),Lind Global Partners II LLC(0%), etc.
Feb 14 09:16
Panbela Therapeutics | 8-K: Current report
Feb 14 06:35
Panbela Therapeutics | 8-K: Current report
Feb 1 20:16
No Data
No Data